Baird Medical Investment Holdings Limited (BDMD) stock forecast & analysis
0.1380
NasdaqCM · USDDelayed by 15 minutes
Down: -0.0224, -14.0%
1 analysis
Latest analysis: · verdict locked
- Open
- 0.1959
- Previous close
- 0.1604
- Day range
- 0.0725 – 0.1960
- 52-week range
- 0.0725 – 3.70
- Volume (shares)
- 169.12M
- Net assets
- Not available
- Expense ratio
- Not available
- Shares outstanding
- 32.11M
- P/E ratio
- Not available
- Dividend yield
- 0.00%
- Beta
- -0.99
- Market cap
- 4.43M
Market Scanner’s AI analysis of Baird Medical Investment Holdings Limited (BDMD), updated November 2026: BDMD's international expansion and distribution agreements contrasted with significant technical oversold conditions and negative profitability.
This page is the public summary. A signed-in user can run a fresh five-stage AI analysis of Baird Medical Investment Holdings Limited (BDMD) and read the full verdict with the bull and bear debate behind it — using Market Scanner tokens, or their own OpenAI or Anthropic key.
Summary
BDMD's international expansion and distribution agreements contrasted with significant technical oversold conditions and negative profitability.
Recent analyses for BDMD covered significant international expansion efforts, including new distribution agreements in China and regulatory progress in Vietnam and Egypt. This was juxtaposed with technical indicators showing the stock trading significantly below key moving averages and in oversold territory. The company's financial performance showed year-over-year revenue growth but reported negative profit margins and a substantial debt load relative to its cash reserves.
BDMD news & sentiment
News coverage highlighted BDMD's international expansion and strategic partnerships, alongside positive revenue growth and net income. Social media discussion was not covered in the provided notes.
BDMD technical picture
The stock traded significantly below its key moving averages, with momentum indicators like the RSI and MFI showing extremely oversold conditions. Price action was below the lower Bollinger Band, confirming bearish momentum.
Fundamentals
The company's quarterly revenue saw year-over-year growth, though its trailing twelve-month profit margin and return on equity were negative. Trailing twelve-month gross profit was substantial, but the company carried significant total debt against a small cash balance, with a quick ratio below one.
Factors discussed — upside
- Quarterly revenue increased 24.6% year-over-year.
- Secured device registrations in Vietnam and advanced approval processes in Egypt.
- Exclusive distribution agreements established in China for microwave ablation technology.
- Reported positive net income for the six-month period ending June 30, 2026.
- Stock showing signs of oversold conditions based on RSI and MFI.
Factors discussed — risks
- Stock trading significantly below 50-day and 200-day SMAs.
- TTM Profit Margin reported at -65.1%.
- TTM Return on Equity reported at -46%.
- Total Debt of $18.88 million compared to Total Cash of $0.40 million.
- Quick Ratio below 1, indicating potential short-term liquidity concerns.
- International Expansion
- Financial Performance
- Technical Indicators
- Strategic Partnerships
Summary updated .
BDMD technical indicators
Common technical indicators for BDMD, computed from its daily closing prices.
| Indicator | Value | Reading |
|---|---|---|
| 50-day simple moving average | 0.79 | Price below |
| 10-day exponential moving average | 0.31 | Price below |
| Relative strength index (14-day) | 13.47 | Oversold |
| MACD line (12/26/9) | -0.1763 | Below its signal line |
| Bollinger bands (20-day, 2σ) | 0.08 – 0.93 | Price inside the bands |
Analyses
Recent BDMD.US analyses are locked — sign in to read them or generate a fresh one.
Locked
Unlock in the library — 1 newer report
Sign in to unlock the 2026-11-03 BDMD.US analysis
Get the verdict — free
Frequently asked questions
- What is the bull case for Baird Medical Investment Holdings Limited?
- The bull case for BDMD centers on its expanding international presence, evidenced by new distribution agreements in China and regulatory approvals in Vietnam and Egypt, alongside reported revenue growth and positive net income for the first half of 2026. Technical indicators also suggest the stock may be oversold.
- What are the risks for Baird Medical Investment Holdings Limited?
- Risks for BDMD include significant technical headwinds, with the stock trading well below key moving averages, and concerning financial metrics such as a negative TTM profit margin and return on equity. The company's debt levels also appear high relative to its cash reserves, and its quick ratio indicates potential short-term liquidity challenges.
- Is Baird Medical Investment Holdings Limited bullish or bearish?
- Recent AI analyses of Baird Medical Investment Holdings Limited examined factors on both sides. Discussed upside: The bull case for BDMD centers on its expanding international presence, evidenced by new distribution agreements in China and regulatory approvals in Vietnam and Egypt, alongside reported revenue growth and positive net income for the first half of 2026. Technical indicators also suggest the stock may be oversold. Discussed risks: Risks for BDMD include significant technical headwinds, with the stock trading well below key moving averages, and concerning financial metrics such as a negative TTM profit margin and return on equity. The company's debt levels also appear high relative to its cash reserves, and its quick ratio indicates potential short-term liquidity challenges. These are descriptive observations, not a recommendation.
- What is the latest sentiment on Baird Medical Investment Holdings Limited?
- News coverage highlighted BDMD's international expansion and strategic partnerships, alongside positive revenue growth and net income. Social media discussion was not covered in the provided notes.
- How does Market Scanner analyse Baird Medical Investment Holdings Limited?
- Every analysis of Baird Medical Investment Holdings Limited runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.Read the methodology
What is the bull case for Baird Medical Investment Holdings Limited?
The bull case for BDMD centers on its expanding international presence, evidenced by new distribution agreements in China and regulatory approvals in Vietnam and Egypt, alongside reported revenue growth and positive net income for the first half of 2026. Technical indicators also suggest the stock may be oversold.
What are the risks for Baird Medical Investment Holdings Limited?
Risks for BDMD include significant technical headwinds, with the stock trading well below key moving averages, and concerning financial metrics such as a negative TTM profit margin and return on equity. The company's debt levels also appear high relative to its cash reserves, and its quick ratio indicates potential short-term liquidity challenges.
Is Baird Medical Investment Holdings Limited bullish or bearish?
Recent AI analyses of Baird Medical Investment Holdings Limited examined factors on both sides. Discussed upside: The bull case for BDMD centers on its expanding international presence, evidenced by new distribution agreements in China and regulatory approvals in Vietnam and Egypt, alongside reported revenue growth and positive net income for the first half of 2026. Technical indicators also suggest the stock may be oversold. Discussed risks: Risks for BDMD include significant technical headwinds, with the stock trading well below key moving averages, and concerning financial metrics such as a negative TTM profit margin and return on equity. The company's debt levels also appear high relative to its cash reserves, and its quick ratio indicates potential short-term liquidity challenges. These are descriptive observations, not a recommendation.
What is the latest sentiment on Baird Medical Investment Holdings Limited?
News coverage highlighted BDMD's international expansion and strategic partnerships, alongside positive revenue growth and net income. Social media discussion was not covered in the provided notes.
How does Market Scanner analyse Baird Medical Investment Holdings Limited?
Every analysis of Baird Medical Investment Holdings Limited runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.
Read the methodology- Bundles used
- gemini-low-v2
Run a fresh BDMD.US analysis
Configure the ticker, model bundle and debate depth here — you only sign in at the end, and everything you picked comes with you.